Computational and Structural Biotechnology JournalBioinformaticsPeer-reviewed journal article
Insights into Heart Failure Metabolite Markersthrough Explainable Machine Learning
Cantin BaroniD, Pamela MehannaiD, Caroline DaneaultiD, Leslie Hausermann, David BusseuiliD, Jean‐Claude TardifiD, Jocelyn DupuisiD, Christine Des RosiersiD, Matthieu RuiziD, Julie HussiniD
Abstract
Understanding molecular traits through metabolomics offers an avenue to tailor cardiovascular prevention, diagnosis and treatment strategies more effectively. This study focuses on the application of machine learning (ML) and explainable artificial intelligence (XAI) algorithms to detect discriminant molecular signatures in heart failure (HF). In this study, we aim to uncover metabolites with significant predictive value by analyzing targeted metabolomics data through ML models and XAI methodologies. After robust quality control procedures, we analyzed 55 metabolites from 124 plasma samples, including 53 HF patients and 71 controls, comparing Logistic Regression (Logit) models with Support Vector Machine (SVM) and eXtreme Gradient Boosting (XGB), all achieving high accuracy in predicting group labels: 84.20% ({sigma} =5.46), 85.73% ({sigma} =6.25), and 84.80% ({sigma} =7.84), respectively. Permutation-based variable importance and Local Interpretable Model-agnostic Explanations (LIME) were used for group-level and individual-level explainability, respectively, complemented by H-Friedman statistics for variable interactions, yielding reliable, explainable insights of the ML models. Metabolites well-known for their association with heart failure, such as glucose and cholesterol, but also more recently described association such C18:1 carnitine, were reaffirmed in our analysis. The novel discovery of lignoceric acid (C24:0 fatty acid) as a critical discriminator, was confirmed in a replication cohort, underscoring its potential as a metabolite marker. Furthermore, our study highlights the utility of 2-way variable interaction analysis in unveiling a network of metabolite interactions essential for accurate disease prediction. The results demonstrate our approachs efficacy in identifying key metabolites and their interactions, illustrating the power of ML and XAI in advancing personalized healthcare solutions. See Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=118 SRC="FIGDIR/small/616718v1_ufig1.gif" ALT="Figure 1"> View larger version (34K): org.highwire.dtl.DTLVardef@d50da1org.highwire.dtl.DTLVardef@171d4d7org.highwire.dtl.DTLVardef@4c8aaaorg.highwire.dtl.DTLVardef@123c1ed_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: metabolomics
- research focus: differential expression
- approach: machine learning (classical)
- Citations
- 7
- FWCI
- 2.11
- Field percentile
- top 14%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Metabolomic profile for understanding heart failure classifications
Maria V. Kozhevnikova, Yu. N. Belenkov, … Svetlana Alexandrovna Appolonova·Scientific ReportsPeer-reviewed·Apr 7, 2025
- Plasma Metabolite Associations with Incident Heart Failure with Reduced and Preserved Ejection Fraction
Bhavya Chebrolu, Priyam Choksi, … Leo Francis Buckley·medRxiv·Jul 22, 2026
- Metabolic Modulation Predicts Heart Failure Tests Performance
D. Contaifer, L. F. Buckley, … D. Wijesinghe·bioRxiv·Feb 20, 2019
- AI-driven Classification of Heart Failure Preserved and Reduced Ejection Fraction Patients Using the Total Protein Approach
Alessio Lenzi, Luís B. Carvalho, … Hugo Miguel Santos·bioRxiv·Nov 25, 2024
- Discovering biomarkers associated and predicting cardiovascular disease with high accuracy using a novel nexus of machine learning techniques for precision medicine
William DeGroat, Habiba Abdelhalim, … Zeeshan Ahmed·Scientific ReportsPeer-reviewed·Jan 2, 2024
- Decoding heart failure subtypes with neural networks via differential explanation analysis
Mariano Ruz Jurado, David Rodríguez Morales, … David John·Briefings in BioinformaticsPeer-reviewed·Nov 1, 2025